PartnerFacts
Data last updated: Oct 23, 2026, 5:45 PM ETLatest filing: Oct 22, 2026Now: Oct 24, 2026, 9:45 AM ET

Sponsor Check › Person

RC
No photo found yet (own website and image search run after this page is viewed)

Robert W. Croce

Named as an officer, director or promoter on SEC Form D filings · CA, FL, MD, NJ · Jul 28, 2009 → Nov 24, 2021

12deals (issuers)
$542.9Mreported sold
631investors
61Form D filings
2009–2021years on file
Follow this personLook further ↓PDF

Data last updated Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 24, 2026, 2:18 AM ET · SEC enforcement last checked: covered by the index scan as of Oct 24, 2026, 2:50 AM ET

The short version

Robert W. Croce is listed as an executive officer and director on 61 SEC Form D filings by 12 issuers between Apr 2009 and Mar 2022. Largest by amount reported sold: Willow Innovations, Inc. (Mountain View, CA — other health care — 2015–2020; $81.4M reported sold to 43 investors), ANCORA HEART, INC. (Santa Clara, CA — other health care — 2010–2021; $80M reported sold to 47 investors), Earlens Corp (Menlo Park, CA — other health care — 2016–2018; $72.1M reported sold to 147 investors), Moximed, Inc (Fremont, CA — other health care — 2009–2017; $62.7M reported sold to 104 investors), NEOTRACT INC (Pleasanton, CA — other health care — 2009–2017; $50.6M reported sold to 71 investors) and 7 more (all listed below).

What this means That is a lot of deals — 12 separate companies raised money with this person listed as executive officer and director, over about 13 years. Across those companies the filings report $542.9M sold in total.

Listed alongside Joshua Makower (22 shared filings), Robert Flanagan (22 shared filings), Ryan Drant (18 shared filings), Mark A. Kielek (15 shared filings), Phillip D. Torrence (15 shared filings) and 99 others.

What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Robert. Each name links to their own page.

The issuers belong to 3 sponsor groups: Exploramed (3 issuers, $65.4M reported sold, 2011–2021), Vascular (2 issuers, $26.3M reported sold, 2009–2022) and Med Tech Arbitrage (6 issuers, $67.5M reported sold, 2009–2026).

What this means This person is listed across more than one sponsor team; each group page shows that team's full track record.

Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CO, CT, DC, DE, FINRA, FL, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VT, WA, WI, WV, WY) — 3 bankruptcy cases matching the name listed in Key records below.

What this means 3 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.

We compared the newest 50 of 61 public filings for Robert W. Croce and found 14 differences, 2 worth asking the sponsor about: 4 bankruptcy cases name the subject or team members; 4 Form Ds were filed more than 15 days after the first sale; and more below.

What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.

What the community is saying

Community search for Robert W. Croce has not run yet — it is #36,314 of 40,243 in line; searches run around the clock at the hosts' allowed rate. Searched so far: 641 names.

Community comments are quoted as written by their authors. Sources searched: Bing (site:reddit.com / site:biggerpockets.com) and Reddit's own search, plus DuckDuckGo/Brave/BiggerPockets search when they are answering.

Key records

Five things investors ask first. Items still in human review are counted, not shown.

1. Lawsuits

None found in sources searched — federal courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30; recall-first rule 10-24) — federal district + bankruptcy courts State courts: not covered (one-tap state court links under Look further). PACER: not searched. · Last checked Oct 24, 2026, 2:18 AM ET.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

2. Regulatory actions

None found in sources searched — SEC enforcement releases (index scan as of Oct 24, 2026, 2:50 AM ET) · state securities regulators: 48 regulators (FINRA, NASAA, 37 states) — crawled Oct 24, 2026, 8:48 AM ET

What was searched

SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — Searched SEC litigation releases and administrative proceedings (1995→ / 2007→) (30,205 records as of Oct 24, 2026, 2:50 AM ET) — nothing matched Robert W. Croce..

State securities regulators: Securities regulators searched (64,910 actions): FINRA (38,350 actions, 1995–2026), NASAA (31 actions, 2000–2026; listing starts 1997), AK Division of Banking and Securities (273 actions, 1971–2025), AL Securities Commission (880 actions, 2001–2026), AR Securities Department (1,305 actions, 1998–2026), AZ Corporation Commission Securities Division (411 actions, 2017–2026), CA DFPI (25 actions, 2007–2024; listing starts 2002 — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), CO Division of Securities (731 actions, 2001–2026; older years from the Internet Archive (snapshot of 2026-05-02)), CT Department of Banking Securities Division (940 actions, 2006–2026; older years from the Internet Archive (snapshot of 2026-04-22)), DC DISB Securities Bureau (25 actions, 2012–2026), DE DOJ Investor Protection Unit (257 actions, 1987–2026), FL Office of Financial Regulation (49 actions, 2018–2026), GA Secretary of State Securities Division (65 actions, 2015–2026; listing starts 2012), HI DCCA Securities Enforcement Branch (26 actions, 2012–2026), ID Department of Finance Securities Bureau (663 actions, 1994–2026), IL Secretary of State Securities Department (4,122 actions, 2003–2023), KS Insurance Department Securities Division (58 actions), KY Department of Financial Institutions (342 actions, 2005–2026), LA Office of Financial Institutions Securities Division (13 actions, 2010–2025; listing starts 2008), MA Secretary of the Commonwealth Securities Division (125 actions, 2012–2025; live site blocks automated access — loaded from the Internet Archive snapshot of 2026-02-04), MD Attorney General Securities Division (1,054 actions, 2004–2026), ME Office of Securities (539 actions, 2000–2026), MI LARA Corporations, Securities & Commercial Licensing Bureau (201 actions), MO Secretary of State Securities Division (919 actions, 1998–2026), MS Secretary of State Securities Division (209 actions, 1995–2026), MT Commissioner of Securities and Insurance (597 actions, 2000–2026), NC Secretary of State Securities Division (265 actions, 2004–2024), ND Securities Department (711 actions, 1990–2026; the regulator no longer publishes this list live — loaded from the Internet Archive snapshot of 2026-01-06), NH Bureau of Securities Regulation (402 actions, 2002–2026), NM Regulation and Licensing Department Securities Division (90 actions, 2010–2025), NV Secretary of State Securities Division (118 actions, 2018–2026), NY Attorney General Investor Protection Bureau (44 actions, 2012–2026), OH Division of Securities (327 actions, 1993–2006), OK Department of Securities (2,531 actions, 1998–2026), OR Division of Financial Regulation (589 actions, 1988–2026), PA Department of Banking and Securities (1,448 actions, 2008–2024; the regulator no longer publishes this list live — loaded from the Internet Archive snapshot of 2024-08-09), RI DBR Securities Division (98 actions, 2005–2025), SC Attorney General Securities Division (540 actions, 2006–2026), SD Division of Insurance – Securities Regulation (106 actions, 2017–2026), TN Department of Commerce and Insurance Securities Division (405 actions, 1992–2026), TX State Securities Board (936 actions, 1999–2026), UT Division of Securities (772 actions, 2000–2026; older years from the Internet Archive (snapshot of 2010-05-27)), VT DFR Securities Division (137 actions, 2010–2026), WA DFI (2,039 actions, 2001–2026), WI DFI Division of Securities (1,072 actions, 1998–2026), WV Securities Commission (State Auditor) (64 actions), WY Secretary of State Compliance Division (6 actions, 2016–2024) — last crawled Oct 24, 2026, 8:48 AM ET. No machine-readable public listing today for IA, IN, MN, NE, NJ, VA (see docs/state-regulators.md).

3. Bankruptcies

3 cases: 3 closed (disposition not in docket feed)

Robert Croce and Monica Croce closed
United States Bankruptcy Court, D. New Jersey · No. 22-14678 · Filed Jun 8, 2022 · Closed Sep 9, 2022
Role of Robert Croce and Monica Croce: Debtor · Outcome: Case closed 2022-09-09 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (rare in federal dockets); court in the person's filing state (NJ); middle initial differs
Robert Della Croce closed
United States Bankruptcy Court, E.D. Missouri · No. 11-40325 · Filed Jan 13, 2011 · Closed Apr 8, 2015
Role of Robert Della Croce: Debtor · Outcome: Case closed 2015-04-08 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (rare in federal dockets); court in MO (not a filing state)
Robert Croce closed
United States Bankruptcy Court, D. Rhode Island · No. 1:91-bk-11056 · Filed Apr 24, 1991 · Closed Sep 6, 1991
Role of Robert Croce: Debtor · Outcome: Case closed 1991-09-06 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (rare in federal dockets); court in RI (not a filing state)
What was searched

Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not covered (one-tap state court links under Look further). PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 2:18 AM ET.

Court records show docket facts only; we never restate allegations as facts. Outcome wording comes from the docket feed; where it does not state a disposition we say so.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

4. Differences between public sources

Comparisons cover issuers and sponsor groups — see the issuer pages under Deals

14 differences found between the filings for Robert W. Croce — 2 worth asking about (compared the newest 50 of 61 filings on Oct 24, 2026; older filings not covered)

Worth asking · Apr 24, 1991 – Apr 8, 2015

4 bankruptcy cases name the subject or team members

Bankruptcy case: Robert Della Croce — filed Jan 13, 2011 · Bankruptcy case: Robert Croce — filed Apr 24, 1991 · Bankruptcy case: Christopher Shen and Yihsuan Ho — filed May 4, 2012 · Bankruptcy case: CHASE BANK USA, N.A. v. Trelles — filed Sep 25, 2007

What this means A bankruptcy filing was found. Many are old or personal and have nothing to do with the deal — but ask what it was and when it closed.

Docket · United States Bankruptcy Court, E.D. Missouri ↗Docket · United States Bankruptcy Court, D. Rhode Island ↗Docket · United States Bankruptcy Court, C.D. California ↗Christopher Shen — PartnerFacts page ↗
Sources
Note · Jun 21, 2012

16% of the money raised went to insiders — SVELTE MEDICAL SYSTEMS INC

The Jun 21, 2012 Form D reports $5,000,000 sold and $800,000 of the proceeds used for payments to officers, directors or promoters (marked as an estimate).

What this means The filing reports how much of the money raised was paid to insiders. Over 10% is high for most deals. Ask what it paid for.

Form D · Jun 21, 2012 ↗SVELTE MEDICAL SYSTEMS INC — PartnerFacts page ↗
Sources
Worth asking · May 27, 2011 – Jul 6, 2021

4 Form Ds were filed more than 15 days after the first sale

Form D filed 112 days after the first sale — ExploraMed V, L.L.C. · Form D filed 18 days after the first sale — ANCORA HEART, INC. · Form D filed 16 days after the first sale — Moximed, Inc · Form D filed 18 days after the first sale — VASCULAR THERAPIES INC

What this means Late notices are common and carry no penalty by themselves. A pattern of late paperwork is worth asking the sponsor about.

Form D · Nov 15, 2017 ↗ExploraMed V, L.L.C. — PartnerFacts page ↗Form D · Jul 6, 2021 ↗ANCORA HEART, INC. — PartnerFacts page ↗
Sources
Note · Oct 14, 2010 – Mar 4, 2022

32 offerings have no amendment in the last 12 months and may still be open

No amendment in the last 12 months on an offering that may still be open — VASCULAR THERAPIES INC (latest filing Mar 4, 2022) · No amendment in the last 12 months on an offering that may still be open — Revelle Aesthetics, Inc. (latest filing Nov 24, 2021) · No amendment in the last 12 months on an offering that may still be open — VASCULAR THERAPIES INC (latest filing Aug 27, 2021) · No amendment in the last 12 months on an offering that may still be open — SVELTE MEDICAL SYSTEMS INC (latest filing May 6, 2021) · No amendment in the last 12 months on an offering that may still be open — Willow Innovations, Inc. (latest filing Oct 1, 2020) · and 27 more

What this means SEC rules expect a yearly amendment while an offering is still going. Ask the sponsor which of these raises have closed.

Form D · Mar 4, 2022 ↗VASCULAR THERAPIES INC — PartnerFacts page ↗Form D/A · Nov 24, 2021 ↗Revelle Aesthetics, Inc. — PartnerFacts page ↗
Sources
Note · Mar 18, 2015 – Feb 22, 2016

Robert W. Croce's role changed at SVELTE MEDICAL SYSTEMS INC: director → executive officer, director

The Mar 18, 2015 filing lists Robert W. Croce as director; the Feb 22, 2016 Form D/A lists executive officer, director.

What this means Roles on Form D are self-reported by the issuer. A change can mean a real change in who runs the company, or just a different box ticked. Ask who makes decisions today.

Form D/A · Mar 18, 2015 ↗Form D/A · Feb 22, 2016 ↗Robert W. Croce — PartnerFacts page ↗SVELTE MEDICAL SYSTEMS INC — PartnerFacts page ↗
Sources
Note · Oct 27, 2010 – Jul 10, 2017

12 offerings changed their target amount between filings

Offering amount changed between filings — SVELTE MEDICAL SYSTEMS INC · Offering amount changed between filings — Earlens Corp · Offering amount changed between filings — VASCULAR THERAPIES INC · Offering amount changed between filings — SVELTE MEDICAL SYSTEMS INC · Offering amount changed between filings — SVELTE MEDICAL SYSTEMS INC · and 7 more

What this means Targets change as deals grow or shrink. Ask whether later money has the same terms.

Form D (earlier) · Jul 27, 2016 ↗Form D/A (later) · Jul 10, 2017 ↗SVELTE MEDICAL SYSTEMS INC — PartnerFacts page ↗Form D (earlier) · Jun 15, 2016 ↗
Sources
Note · Jun 7, 2011 – Dec 5, 2011

Minimum investment changed between filings — Moximed, Inc

The Jun 7, 2011 filing lists a minimum of $2; the Dec 5, 2011 Form D/A lists $1.

What this means A different minimum usually means the offering terms changed. Check which terms apply to you.

Form D (earlier) · Jun 7, 2011 ↗Form D/A (later) · Dec 5, 2011 ↗Moximed, Inc — PartnerFacts page ↗
Sources
Note · Oct 27, 2010 – May 16, 2011

Robert W. Croce is written 2 different ways on the filings

listed as "Robert Croce" on 36 filings (from Oct 27, 2010), and "Robert W. Croce" on 15 filings (from May 16, 2011).

What this means Same person, written differently — a middle name or suffix left off, or spelled another way. It is normal, but check that the full legal name matches your subscription documents.

Form D · Oct 27, 2010 ↗Form D · May 16, 2011 ↗Robert W. Croce — PartnerFacts page ↗
Sources
Note · Jun 6, 2011 – Nov 18, 2013

Industry group changed between filings — ARSTASIS INC

"Other" (Jun 6, 2011 to Jun 22, 2012); then "Other Health Care" (Nov 18, 2013).

What this means The issuer described its business differently on different forms. Often it is just a different box ticked; sometimes the deal itself changed. Ask which business your money is in.

Form D · Jun 6, 2011 ↗Form D · Nov 18, 2013 ↗ARSTASIS INC — PartnerFacts page ↗
Sources
Note · Oct 27, 2010 – Jun 21, 2012

Industry group changed between filings — SVELTE MEDICAL SYSTEMS INC

"Biotechnology" (Oct 27, 2010 to Jul 15, 2011); then "Other Health Care" (Dec 14, 2011); then "Biotechnology" (Jun 21, 2012 to May 6, 2021).

What this means The issuer described its business differently on different forms. Often it is just a different box ticked; sometimes the deal itself changed. Ask which business your money is in.

Form D · Oct 27, 2010 ↗Form D · Dec 14, 2011 ↗Form D · Jun 21, 2012 ↗SVELTE MEDICAL SYSTEMS INC — PartnerFacts page ↗
Sources
Note · May 16, 2011 – May 22, 2012

Industry group changed between filings — Vibrynt, INc

"Other" (May 16, 2011); then "Other Health Care" (May 22, 2012).

What this means The issuer described its business differently on different forms. Often it is just a different box ticked; sometimes the deal itself changed. Ask which business your money is in.

Form D · May 16, 2011 ↗Form D · May 22, 2012 ↗Vibrynt, INc — PartnerFacts page ↗
Sources
Note · Oct 27, 2010 – Feb 22, 2016

Reported revenue range changed between filings — SVELTE MEDICAL SYSTEMS INC

"$1 - $1,000,000" (Oct 27, 2010); then "Decline to Disclose" (Feb 22, 2016).

What this means This is the size band the issuer picks for itself on the form. A change can mean the business grew or shrank — or that it chose not to say. Ask for current numbers.

Form D · Oct 27, 2010 ↗Form D/A · Feb 22, 2016 ↗SVELTE MEDICAL SYSTEMS INC — PartnerFacts page ↗
Sources
Note · May 16, 2011 – Feb 19, 2015

4 address changes between filings

Address moved from Wilson, WY to Cresskill, NJ — VASCULAR THERAPIES INC · Address moved from Kalamazoo, MI to New Providence, NJ — SVELTE MEDICAL SYSTEMS INC · Address moved from Stuart, FL to Wilson, WY — VASCULAR THERAPIES INC · Address moved from Baltimore, MD to Redwood City, CA — Vibrynt, INc

What this means Businesses move. If you were told one city and the forms say another, ask which is current.

Form D/A · Jul 12, 2013 ↗Form D · Feb 19, 2015 ↗VASCULAR THERAPIES INC — PartnerFacts page ↗Form D · Jun 21, 2012 ↗
Sources
Note · Oct 27, 2010 – Mar 4, 2022

Robert W. Croce is listed with 4 different address states: FL, MD, CA, NJ

FL on 7 filings (Oct 27, 2010 to Jul 12, 2013); MD on 1 filing (May 16, 2011); CA on 26 filings (Jun 6, 2011 to Nov 24, 2021); NJ on 17 filings (Apr 29, 2013 to Mar 4, 2022).

What this means The address on a Form D is usually the company's, not the person's home, so this often just reflects different companies. It can also mean a move. Nothing wrong by itself.

Form D · Oct 27, 2010 ↗Form D · May 16, 2011 ↗Form D · Jun 6, 2011 ↗Form D · Apr 29, 2013 ↗
Sources
What is compared

What is compared: every Form D and D/A we hold for this subject, side by side — filing dates vs. first-sale dates (the 15-day rule), amendment timing on open offerings (the yearly-amendment expectation), amounts sold, investor counts, offering amounts and minimums across amendments, industry and size bands, addresses, how each person's name and role is written, paid sellers' CRD numbers, and (for groups) where the member companies were formed and sit. Everything is as filed by the issuer; the SEC does not check it. Differences are common and usually have ordinary explanations — we show both values, the dates, and the source so you can ask. We compared the newest 50 of 61 filings (work cap); older filings are not covered here. As of Oct 24, 2026.

5. Money to insiders

2 of 46 offerings report sales commissions totalling $1,180,000; 0 report finder's fees; 4 report proceeds to related persons totalling $3,114,642. (includes amounts the issuer reported as estimates)

Offering (latest filing)Sales commissionsFinder's feesTo insidersPaid to sell itSource
Mar 4, 2022 D
VASCULAR THERAPIES INC
File 021-435950
$0$0$0None listed on this filingEDGAR ↗
Nov 24, 2021 D/A
Revelle Aesthetics, Inc.
File 021-372142
$0$0$0None listed on this filingEDGAR ↗
Aug 27, 2021 D
VASCULAR THERAPIES INC
File 021-411490
$0$0$0None listed on this filingEDGAR ↗
Jul 6, 2021 D
ANCORA HEART, INC.
File 021-405300
$0$0$0None listed on this filingEDGAR ↗
May 6, 2021 D
SVELTE MEDICAL SYSTEMS INC
File 021-398487
$0 (est.)$0 (est.)$0 (est.)None listed on this filingEDGAR ↗
Oct 1, 2020 D
Willow Innovations, Inc.
File 021-376907
$0$0$0None listed on this filingEDGAR ↗
Nov 21, 2019 D
VASCULAR THERAPIES INC
File 021-353952
$0$0$0None listed on this filingEDGAR ↗
Aug 15, 2019 D
Willow Innovations, Inc.
File 021-346616
$0$0$0None listed on this filingEDGAR ↗
Dec 28, 2018 D
ANCORA HEART, INC.
File 021-329171
$0$0$0None listed on this filingEDGAR ↗
Oct 12, 2018 D
VASCULAR THERAPIES INC
File 021-323465
$0$0$0None listed on this filingEDGAR ↗
May 31, 2018 D
ANCORA HEART, INC.
File 021-313621
$0$0$0None listed on this filingEDGAR ↗
May 24, 2018 D
Earlens Corp
File 021-313186
$0$0$0None listed on this filingEDGAR ↗
Dec 12, 2017 D
Willow Innovations, Inc.
File 021-300471
$0$0$0None listed on this filingEDGAR ↗
Nov 21, 2017 D
SVELTE MEDICAL SYSTEMS INC
File 021-299301
$0 (est.)$0$0 (est.)None listed on this filingEDGAR ↗
Nov 15, 2017 D
ExploraMed V, L.L.C.
File 021-298843
$0$0$0None listed on this filingEDGAR ↗
Jul 10, 2017 D/A
SVELTE MEDICAL SYSTEMS INC
File 021-267790
$0 (est.)$0$0 (est.)None listed on this filingEDGAR ↗
May 25, 2017 D/A
Earlens Corp
File 021-265112
$0$0$0None listed on this filingEDGAR ↗
Mar 31, 2017 D
Moximed, Inc
File 021-283747
$0$0$0None listed on this filingEDGAR ↗
Jan 6, 2017 D
NEOTRACT INC
File 021-277831
$0$0$0None listed on this filingEDGAR ↗
Dec 30, 2016 D/A
VASCULAR THERAPIES INC
File 021-234314
$0$0$0None listed on this filingEDGAR ↗
Jul 27, 2016 D/A
SVELTE MEDICAL SYSTEMS INC
File 021-206072
$430,000 (est.)$0$1,360,000 (est.)Piper Jaffray & Co. BrokerCheck CRD 655 ↗EDGAR ↗
May 5, 2015 D
Moximed, Inc
File 021-239193
$0$0$0None listed on this filingEDGAR ↗
Mar 9, 2015 D/A
Willow Innovations, Inc.
File 021-232596
$0$0$0None listed on this filingEDGAR ↗
Jan 28, 2014 D/A
NEOTRACT INC
File 021-178788
$0$0$0None listed on this filingEDGAR ↗
Nov 18, 2013 D
ARSTASIS INC
File 021-206492
$0$0$0None listed on this filingEDGAR ↗
Jul 12, 2013 D/A
VASCULAR THERAPIES INC
File 021-181224
$750,000 (est.)$0$0ROBERTS MITANI, LLC BrokerCheck CRD 30022 ↗EDGAR ↗
Jun 4, 2013 D/A
SVELTE MEDICAL SYSTEMS INC
File 021-195730
$0$0$229,642 (est.)None listed on this filingEDGAR ↗
Jun 22, 2012 D
ARSTASIS INC
File 021-180202
$0$0$0None listed on this filingEDGAR ↗
Jun 21, 2012 D
SVELTE MEDICAL SYSTEMS INC
File 021-180116
$0$0$800,000 (est.)None listed on this filingEDGAR ↗
May 22, 2012 D
Vibrynt, INc
File 021-178652
$0$0$0None listed on this filingEDGAR ↗
Dec 14, 2011 D
SVELTE MEDICAL SYSTEMS INC
File 021-170051
$0$0$0 (est.)None listed on this filingEDGAR ↗
Dec 5, 2011 D/A
Moximed, Inc
File 021-160894
$0$0$0None listed on this filingEDGAR ↗
Nov 25, 2011 D
ExploraMed IV, L.L.C.
File 021-169229
$0$0$0None listed on this filingEDGAR ↗
Jul 15, 2011 D/A
SVELTE MEDICAL SYSTEMS INC
File 021-149681
$0$0$725,000 (est.)None listed on this filingEDGAR ↗
Jun 14, 2011 D
VASCULAR THERAPIES INC
File 021-161241
$0$0$0 (est.)None listed on this filingEDGAR ↗
Jun 6, 2011 D
ARSTASIS INC
File 021-160812
$0$0$0None listed on this filingEDGAR ↗
May 16, 2011 D
Vibrynt, INc
File 021-159861
$0$0$0None listed on this filingEDGAR ↗
Apr 25, 2011 D
VASCULAR THERAPIES INC
File 021-158825
$0$0$0None listed on this filingEDGAR ↗
Apr 25, 2011 D
VASCULAR THERAPIES INC
File 021-158826
$0$0$0None listed on this filingEDGAR ↗
Apr 25, 2011 D
VASCULAR THERAPIES INC
File 021-158827
$0$0$0None listed on this filingEDGAR ↗
Feb 4, 2011 D
NEOTRACT INC
File 021-154828
$0$0$0None listed on this filingEDGAR ↗
Apr 28, 2010 D
ANCORA HEART, INC.
File 021-141256
$0$0$0None listed on this filingEDGAR ↗
Mar 16, 2010 D/A
SVELTE MEDICAL SYSTEMS INC
File 021-102229
$0$0$0None listed on this filingEDGAR ↗
Oct 26, 2009 D/A
NEOTRACT INC
File 021-87399
$0$0$0None listed on this filingEDGAR ↗
Aug 14, 2009 D
Moximed, Inc
File 021-117353
$0$0$0None listed on this filingEDGAR ↗
Apr 27, 2009 D
ARSTASIS INC
File 021-87118
$0$0$0None listed on this filingEDGAR ↗
How this is counted

Counts come from Form D Items 12–15 on the filings in our index (latest filing per offering; one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.

Counted across every filing this person is listed on (latest filing per offering, per issuer).

Deals 12

Every issuer that named Robert W. Croce on a Form D, newest first. A Form D is the notice a company files after it starts selling a private investment.

VT
Biotechnology · group: Vascular

VASCULAR THERAPIES INC

Cresskill, NJ · Apr 25, 2011 → Mar 4, 2022 · 12 filings
  • Mar 4, 2022 · D · $23,963,442 sold of $25,213,472 · 54 investors · min. No minimum reported · role: Director EDGAR ↗
  • Aug 27, 2021 · D · $3,748,712 sold of $4,000,000 · 96 investors · min. No minimum reported · role: Director EDGAR ↗
  • Nov 21, 2019 · D · $7,382,500 sold of $14,765,000 · 39 investors · min. No minimum reported · role: Director EDGAR ↗
  • Oct 12, 2018 · D · $12,360,000 sold of $21,100,000 · 29 investors · min. No minimum reported · role: Director EDGAR ↗
  • Dec 30, 2016 · D/A · $31,000,000 sold of $31,000,000 · 33 investors · min. No minimum reported · role: Director EDGAR ↗
  • Feb 19, 2015 · D · $16,200,000 sold of $27,000,000 · 30 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jul 12, 2013 · D/A · $5,195,226 sold of $14,999,994 · 11 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jul 13, 2012 · D · $2,499,999 sold of $14,999,994 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jun 14, 2011 · D · $3,159,325 sold of $5,000,000 · 30 investors · min. No minimum reported · role: Director EDGAR ↗
  • Apr 25, 2011 · D · $1,375,000 sold of $1,375,000 · 22 investors · min. No minimum reported · role: Director EDGAR ↗
  • Apr 25, 2011 · D · $348,000 sold of $348,000 · 16 investors · min. No minimum reported · role: Director EDGAR ↗
  • Apr 25, 2011 · D · $646,340 sold of $646,340 · 23 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $31M from 96 investors (100% of the $25.2M target) as of the latest filing. Robert is listed as director on 12 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

RA
Other Health Care · group: Exploramed

Revelle Aesthetics, Inc.

Mountain View, CA · Jul 30, 2020 → Nov 24, 2021 · 2 filings
  • Nov 24, 2021 · D/A · $49,999,855 sold of $49,999,996 · 36 investors · min. $1 · role: Director EDGAR ↗
  • Jul 30, 2020 · D · $24,999,996 sold of $49,999,996 · 3 investors · min. $1 · role: Director EDGAR ↗

Raised $50M from 36 investors (100% of the $50M target) as of the latest filing. Robert is listed as director on 2 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

AH
Other Health Care

ANCORA HEART, INC.

Santa Clara, CA · Apr 28, 2010 → Jul 6, 2021 · 4 filings
  • Jul 6, 2021 · D · $80,000,000 sold of $80,000,000 · 47 investors · min. No minimum reported · role: Director EDGAR ↗
  • Dec 28, 2018 · D · $23,460,256 sold of $35,000,000 · 5 investors · min. No minimum reported · role: Director EDGAR ↗
  • May 31, 2018 · D · $17,839,844 sold of $30,000,001 · 32 investors · min. No minimum reported · role: Director EDGAR ↗
  • Apr 28, 2010 · D · $29,999,998 sold of $29,999,998 · 1 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $80M from 47 investors (100% of the $80M target) as of the latest filing. Robert is listed as director on 4 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

SM
Biotechnology

SVELTE MEDICAL SYSTEMS INC

New Providence, NJ · Mar 16, 2010 → May 6, 2021 · 16 filings
  • May 6, 2021 · D · $5,445,363 sold of $10,845,671 · 17 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • Nov 21, 2017 · D · $3,000,000 sold of $52,000,000 · 10 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • Jul 10, 2017 · D/A · $12,300,000 sold of $15,000,000 · 9 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • Jul 27, 2016 · D · $4,000,000 sold of $10,000,000 · 4 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • Jul 27, 2016 · D/A · $50,402,467 sold of $50,796,673 · 39 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • Feb 22, 2016 · D/A · $44,402,467 sold of $46,636,324 · 37 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • Mar 18, 2015 · D/A · $38,008,324 sold of $42,736,324 · 30 investors · min. No minimum reported · role: Director EDGAR ↗
  • Mar 12, 2014 · D/A · $26,636,324 sold of $26,636,324 · 27 investors · min. No minimum reported · role: Director EDGAR ↗
  • Nov 8, 2013 · D · $17,931,354 sold of $21,637,118 · 26 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jun 4, 2013 · D/A · $4,307,884 sold of $5,470,329 · 7 investors · min. No minimum reported · role: Director EDGAR ↗
  • Apr 29, 2013 · D · $1,809,555 sold of $3,000,000 · 3 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jun 21, 2012 · D · $5,000,000 sold of $7,000,000 · 13 investors · min. No minimum reported · role: Director EDGAR ↗
  • Dec 14, 2011 · D · $18,784,666 sold of $35,000,000 · 22 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jul 15, 2011 · D/A · $9,694,400 sold of $12,000,000 · 22 investors · min. No minimum reported · role: Director EDGAR ↗
  • Oct 27, 2010 · D · $4,492,700 sold of $6,000,000 · 14 investors · min. No minimum reported · role: Director EDGAR ↗
  • Mar 16, 2010 · D/A · $4,151,043 sold of $10,000,000 · 22 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $50.4M from 39 investors (100% of the $10.8M target) as of the latest filing. Robert is listed as executive officer, director on 16 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

WI
Other Health Care

Willow Innovations, Inc.

Mountain View, CA · Jan 21, 2015 → Oct 1, 2020 · 5 filings
  • Oct 1, 2020 · D · $32,512,388 sold of $45,169,431 · 35 investors · min. $1 · role: Director EDGAR ↗
  • Aug 15, 2019 · D · $22,696,912 sold of $29,478,861 · 7 investors · min. $1 · role: Director EDGAR ↗
  • Dec 12, 2017 · D · $27,470,204 sold of $31,189,200 · 12 investors · min. $1 · role: Director EDGAR ↗
  • Mar 9, 2015 · D/A · $17,410,000 sold of $17,500,000 · 43 investors · min. $1 · role: Director EDGAR ↗
  • Jan 21, 2015 · D · $15,000,000 sold of $16,000,000 · 5 investors · min. $1 · role: Director EDGAR ↗

Raised $81.4M from 43 investors (100% of the $45.2M target) as of the latest filing. Robert is listed as director on 5 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

EC
Other Health Care

Earlens Corp

Menlo Park, CA · Jun 15, 2016 → May 24, 2018 · 3 filings
  • May 24, 2018 · D · $9,006,378 sold of $20,000,000 · 21 investors · min. No minimum reported · role: Director EDGAR ↗
  • May 25, 2017 · D/A · $72,121,791 sold of $77,274,197 · 59 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jun 15, 2016 · D · $53,593,010 sold of $69,029,068 · 22 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $72.1M from 147 investors (100% of the $20M target) as of the latest filing. Robert is listed as director on 3 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

EV
Other Health Care · group: Exploramed

ExploraMed V, L.L.C.

Mountain View, CA · Nov 15, 2017
  • Nov 15, 2017 · D · $8,756,650 sold of $8,756,650 · 28 investors · min. $1 · role: Director EDGAR ↗

Raised $8.76M from 28 investors (100% of the $8.76M target) as of the latest filing. Robert is listed as director.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

M
Other Health Care · group: Med Tech Arbitrage

Moximed, Inc

Fremont, CA · Aug 14, 2009 → Mar 31, 2017 · 5 filings
  • Mar 31, 2017 · D · $49,541,720 sold of $51,450,000 · 8 investors · min. $1 · role: Director EDGAR ↗
  • May 5, 2015 · D · $19,742,755 sold of $37,642,028 · 104 investors · min. $1 · role: Director EDGAR ↗
  • Dec 5, 2011 · D/A · $45,837,656 sold of $45,862,892 · 55 investors · min. $1 · role: Director EDGAR ↗
  • Jun 7, 2011 · D · $43,269,656 sold of $45,300,000 · 6 investors · min. $2 · role: Director EDGAR ↗
  • Aug 14, 2009 · D · $10,000,000 sold of $11,000,000 · 2 investors · min. $2 · role: Director EDGAR ↗

Raised $62.7M from 104 investors (100% of the $51.5M target) as of the latest filing. Robert is listed as director on 5 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

N
Other Health Care

NEOTRACT INC

Pleasanton, CA · Jul 28, 2009 → Jan 6, 2017 · 6 filings
  • Jan 6, 2017 · D · $12,816,967 sold of $14,999,999 · 12 investors · min. $1 · role: Director EDGAR ↗
  • Jan 28, 2014 · D/A · $50,556,684 sold of $56,700,000 · 71 investors · min. $1 · role: Director EDGAR ↗
  • May 24, 2012 · D · $32,399,995 sold of $40,320,000 · 12 investors · min. $1 · role: Director EDGAR ↗
  • Feb 4, 2011 · D · $25,999,999 sold of $27,331,840 · 5 investors · min. $1 · role: Director EDGAR ↗
  • Oct 26, 2009 · D/A · $28,108,160 sold of $30,240,000 · 15 investors · min. $1 · role: Director EDGAR ↗
  • Jul 28, 2009 · D · $23,733,044 sold of $25,200,000 · 3 investors · min. $1 · role: Director EDGAR ↗

Raised $50.6M from 71 investors (100% of the $15M target) as of the latest filing. Robert is listed as director on 6 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

A
Other Health Care

ARSTASIS INC

Redwood City, CA · Apr 27, 2009 → Nov 18, 2013 · 4 filings
  • Nov 18, 2013 · D · $16,499,998 sold of $18,999,998 · 2 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jun 22, 2012 · D · $37,837,305 sold of $51,179,299 · 14 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jun 6, 2011 · D · $25,521,743 sold of $25,521,743 · 12 investors · min. No minimum reported · role: Director EDGAR ↗
  • Apr 27, 2009 · D · $22,400,005 sold of $22,400,005 · 13 investors · min. $11 · role: Director EDGAR ↗

Raised $37.8M from 14 investors (100% of the $19M target) as of the latest filing. Robert is listed as director on 4 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

V
Other Health Care

Vibrynt, INc

Redwood City, CA · May 16, 2011 → May 22, 2012 · 2 filings
  • May 22, 2012 · D · $2,750,000 sold of $5,500,000 · 5 investors · min. $1 · role: Director EDGAR ↗
  • May 16, 2011 · D · $11,500,000 sold of $11,500,000 · 5 investors · min. $1 · role: Director EDGAR ↗

Raised $11.5M from 5 investors (100% of the $5.5M target) as of the latest filing. Robert is listed as director on 2 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

EL
Other · group: Exploramed

ExploraMed IV, L.L.C.

Mountain View, CA · Nov 25, 2011
  • Nov 25, 2011 · D · $6,600,000 sold of $8,000,000 · 1 investors · min. $1 · role: Director EDGAR ↗

Raised $6.6M from 1 investor (83% of the $8M target) as of the latest filing. Robert is listed as director.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

People around Robert 40

Officers, directors, promoters and management entities named on the same filings, as of Oct 23, 2026, 5:45 PM ET. Showing the 40 with the most shared filings.

JM
No photo found yet (own website and image search run after this page is viewed)
Person

Joshua Makower

Director, Executive Officer · 22 shared filings (7 issuers) · also on 9 other issuers

Joshua Makower is on 16 issuers in total — a repeat sponsor. Their page lists every one.

RF
No photo found yet (own website and image search run after this page is viewed)
Person

Robert Flanagan

Director · 22 shared filings (2 issuers) · also on 2 other issuers

Listed on the same filings as Robert W. Croce. Their page shows their other deals.

RD
No photo found yet (own website and image search run after this page is viewed)
Person

Ryan Drant

Director · 18 shared filings (6 issuers) · also on 32 other issuers

Ryan Drant is on 38 issuers in total — a repeat sponsor. Their page lists every one.

PT
No photo found yet (own website and image search run after this page is viewed)
Person

Phillip D. Torrence

Executive Officer · 15 shared filings (1 issuer) · also on 4 other issuers

Phillip D. Torrence is on 5 issuers in total — a repeat sponsor. Their page lists every one.

MK
No photo found yet (own website and image search run after this page is viewed)
Person

Mark A. Kielek

Executive Officer · 15 shared filings (1 issuer)

Listed on the same filings as Robert W. Croce. Their page shows their other deals.

SS
No photo found yet (own website and image search run after this page is viewed)
Person

Somu Subramaniam

Director · 13 shared filings (2 issuers) · also on 2 other issuers

Listed on the same filings as Robert W. Croce. Their page shows their other deals.

GD
No photo found yet (own website and image search run after this page is viewed)
Person

Gerald Dorros

Director · 12 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Robert W. Croce. Their page shows their other deals.

SI
No photo found yet (own website and image search run after this page is viewed)
Person

Sriram Iyer

Executive Officer, Director · 12 shared filings (1 issuer)

Listed on the same filings as Robert W. Croce. Their page shows their other deals.

JN
No photo found yet (own website and image search run after this page is viewed)
Person

John Nehra

Director · 11 shared filings (4 issuers) · also on 12 other issuers

John Nehra is on 16 issuers in total — a repeat sponsor. Their page lists every one.

JD
No photo found yet (own website and image search run after this page is viewed)
Person

Jack Darby

Executive Officer, Director · 11 shared filings (1 issuer)

Listed on the same filings as Robert W. Croce. Their page shows their other deals.

RA
No photo found yet (own website and image search run after this page is viewed)
Person

Robert Anderson

Director · 10 shared filings (6 issuers) · also on 11 other issuers

Robert Anderson is on 17 issuers in total — a repeat sponsor. Their page lists every one.

MP
No photo found yet (own website and image search run after this page is viewed)
Person

Mark Pomeranz

Executive Officer, Director · 9 shared filings (1 issuer)

Listed on the same filings as Robert W. Croce. Their page shows their other deals.

HP
No photo found yet (own website and image search run after this page is viewed)
Person

Henry A. Plain, Jr.

Director · 8 shared filings (2 issuers) · also on 12 other issuers

Henry A. Plain, Jr. is on 14 issuers in total — a repeat sponsor. Their page lists every one.

DA
No photo found yet (own website and image search run after this page is viewed)
Person

David C. Auth

Director · 8 shared filings (2 issuers) · also on 3 other issuers

David C. Auth is on 5 issuers in total — a repeat sponsor. Their page lists every one.

LP
No photo found yet (own website and image search run after this page is viewed)
Person

Lewis Pell

Executive Officer, Director · 8 shared filings (2 issuers) · also on 3 other issuers

Lewis Pell is on 5 issuers in total — a repeat sponsor. Their page lists every one.

MB
No photo found yet (own website and image search run after this page is viewed)
Person

Michael Bamberger

Director · 8 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Robert W. Croce. Their page shows their other deals.

AT
No photo found yet (own website and image search run after this page is viewed)
Person

Allan Tessler

Director · 8 shared filings (1 issuer)

Listed on the same filings as Robert W. Croce. Their page shows their other deals.

TF
No photo found yet (own website and image search run after this page is viewed)
Person

Tim A. Fischell

Executive Officer · 7 shared filings (1 issuer) · also on 4 other issuers

Tim A. Fischell is on 5 issuers in total — a repeat sponsor. Their page lists every one.

RF
No photo found yet (own website and image search run after this page is viewed)
Person

Robert E. Fischell

Executive Officer, Director · 7 shared filings (1 issuer) · also on 7 other issuers

Robert E. Fischell is on 8 issuers in total — a repeat sponsor. Their page lists every one.

MS
No photo found yet (own website and image search run after this page is viewed)
Person

Mina Sooch

Director · 7 shared filings (1 issuer) · also on 6 other issuers

Mina Sooch is on 7 issuers in total — a repeat sponsor. Their page lists every one.

DF
No photo found yet (own website and image search run after this page is viewed)
Person

David R. Fischell

Director · 7 shared filings (1 issuer) · also on 7 other issuers

David R. Fischell is on 8 issuers in total — a repeat sponsor. Their page lists every one.

RD
No photo found yet (own website and image search run after this page is viewed)
Person

Richard Dakers

Director · 7 shared filings (1 issuer)

Listed on the same filings as Robert W. Croce. Their page shows their other deals.

RA
No photo found yet (own website and image search run after this page is viewed)
Person

Robert K. Anderson

Director · 7 shared filings (3 issuers) · also on 1 other issuer

Listed on the same filings as Robert W. Croce. Their page shows their other deals.

AM
No photo found yet (own website and image search run after this page is viewed)
Person

Andrew Midler

Director · 7 shared filings (2 issuers) · also on 5 other issuers

Andrew Midler is on 7 issuers in total — a repeat sponsor. Their page lists every one.

WF
No photo found yet (own website and image search run after this page is viewed)
Person

William Facteau

Director, Executive Officer · 6 shared filings (2 issuers) · also on 3 other issuers

William Facteau is on 5 issuers in total — a repeat sponsor. Their page lists every one.

RS
No photo found yet (own website and image search run after this page is viewed)
Person

Richard T. Spencer

Executive Officer · 6 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Robert W. Croce. Their page shows their other deals.

KT
No photo found yet (own website and image search run after this page is viewed)
Person

Kiyoshi Takesue

Director · 6 shared filings (1 issuer)

Listed on the same filings as Robert W. Croce. Their page shows their other deals.

NR
No photo found yet (own website and image search run after this page is viewed)
Person

Nina Richardson

Director · 6 shared filings (3 issuers) · also on 1 other issuer

Listed on the same filings as Robert W. Croce. Their page shows their other deals.

TL
No photo found yet (own website and image search run after this page is viewed)
Person

Theodore Lamson

Executive Officer, Director · 6 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Robert W. Croce. Their page shows their other deals.

KS
No photo found yet (own website and image search run after this page is viewed)
Person

Kevin Sidow

Executive Officer, Director · 5 shared filings (1 issuer) · also on 6 other issuers

Kevin Sidow is on 7 issuers in total — a repeat sponsor. Their page lists every one.

DA
No photo found yet (own website and image search run after this page is viewed)
Person

David Amerson

Executive Officer, Director · 5 shared filings (2 issuers) · also on 3 other issuers

David Amerson is on 5 issuers in total — a repeat sponsor. Their page lists every one.

MC
No photo found yet (own website and image search run after this page is viewed)
Person

Michael Carusi

Director · 5 shared filings (1 issuer) · also on 16 other issuers

Michael Carusi is on 17 issuers in total — a repeat sponsor. Their page lists every one.

GN
No photo found yet (own website and image search run after this page is viewed)
Person

Glen Nelson

Director · 5 shared filings (2 issuers) · also on 4 other issuers

Glen Nelson is on 6 issuers in total — a repeat sponsor. Their page lists every one.

BM
No photo found yet (own website and image search run after this page is viewed)
Person

Bruce Modesitt

Executive Officer, Director · 4 shared filings (1 issuer)

Listed on the same filings as Robert W. Croce. Their page shows their other deals.

NS
No photo found yet (own website and image search run after this page is viewed)
Person

Niel F. Starksen

Director, Executive Officer · 4 shared filings (2 issuers)

Listed on the same filings as Robert W. Croce. Their page shows their other deals.

MS
No photo found yet (own website and image search run after this page is viewed)
Person

Maria Sainz

Director · 4 shared filings (1 issuer) · also on 3 other issuers

Listed on the same filings as Robert W. Croce. Their page shows their other deals.

MJ
No photo found yet (own website and image search run after this page is viewed)
Person

Michael Johnson

Executive Officer · 4 shared filings (1 issuer)

Listed on the same filings as Robert W. Croce. Their page shows their other deals.

KK
No photo found yet (own website and image search run after this page is viewed)
Person

Kadir Kadhiresan

Director · 4 shared filings (1 issuer) · also on 7 other issuers

Kadir Kadhiresan is on 8 issuers in total — a repeat sponsor. Their page lists every one.

PB
No photo found yet (own website and image search run after this page is viewed)
Person

Paul Barkofsky

Executive Officer, Director · 4 shared filings (1 issuer)

Listed on the same filings as Robert W. Croce. Their page shows their other deals.

SL
No photo found yet (own website and image search run after this page is viewed)
Person

Samuel M. Liang

Director · 4 shared filings (1 issuer)

Listed on the same filings as Robert W. Croce. Their page shows their other deals.

The team behind the deals

E
Sponsor group

Exploramed

3 issuers · 4 filings · $65.4M reported sold · 2011–2021

One team, 3 deal companies. Robert W. Croce is listed on 3 of them.

Sources

Issuers are grouped when their Form D filings share related persons, a management entity or a business address (automatic match from the filings). "Listed" marks the issuers that name Robert W. Croce.

V
Sponsor group

Vascular

2 issuers · 13 filings · $26.3M reported sold · 2009–2022

One team, 2 deal companies. Robert W. Croce is listed on 1 of them.

Sources

Issuers are grouped when their Form D filings share related persons, a management entity or a business address (automatic match from the filings). "Listed" marks the issuers that name Robert W. Croce.

MT
Sponsor group

Med Tech Arbitrage

6 issuers · 13 filings · $67.5M reported sold · 2009–2026

One team, 6 deal companies. Robert W. Croce is listed on 1 of them.

Sources

Issuers are grouped when their Form D filings share related persons, a management entity or a business address (automatic match from the filings). "Listed" marks the issuers that name Robert W. Croce.

Registrations and other filings

Business registration (state registry / Secretary of State)

Individuals are not matched to business registrations — registries list companies, and a name alone is not enough to tie a person to one. Officers and managers appear by name inside each matched company's record on the issuer pages. Registries searched: AL (Alabama Secretary of State — Business Entity Records (arc-sos.state.al.us), searched by issuer name, data as of Oct 24, 2026); CO (Colorado Secretary of State — Business Entities in Colorado (data.colorado.gov), data as of Oct 23, 2026); CT (Connecticut Secretary of the State — Business Registry (data.ct.gov), data as of Oct 24, 2026); FL (Florida Department of State, Division of Corporations — quarterly corporate data file (Sunbiz), data as of Oct 7, 2026); NY (New York Department of State — Corporations and Other Entities (data.ny.gov: All Filings + Active Corporations), data as of Oct 20, 2026); OR (Oregon Secretary of State — Active Businesses, All (data.oregon.gov), data as of Oct 20, 2026); PA (Pennsylvania Department of State — Registered Businesses, Current (data.pa.gov), data as of Oct 6, 2026); TX (Texas Comptroller — Active Franchise Taxpayers incl. Secretary of State file data (data.texas.gov), data as of Oct 24, 2026). Registries of other states have not been searched: many publish no bulk file and require a CAPTCHA or bot challenge on their search page, which we do not bypass (Delaware, for example, offers no public bulk file).

Adviser registration (Form ADV)

None of the 12 issuers this person is listed on appears in Form ADV (searched 24,962 advisers as of Oct 2, 2026). A person is never an adviser firm; Form ADV is checked for the issuers and the management companies they are listed with.

Other offering types (Regulation A and Regulation Crowdfunding)

Searched SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 (51,358 records as of Oct 23, 2026, 8:41 PM ET) — nothing matched this name.

Property records none — individuals are not matched

Property records are matched to companies only, never to individuals, so none are matched to Robert W. Croce by design. Searched property records in Hillsborough County FL (Clerk recorded-document index Oct 14, 2026 to Oct 15, 2026 + FL DOR 2026 ownership roll), Miami-Dade County FL (FL DOR 2026 ownership roll), Harris County TX (HCAD 2026 ownership roll), Dallas County TX (DCAD 2026 ownership roll), New York City ACRIS documents and PLUTO ownership rows already retrieved for other issuers, Cook County IL sale and ownership rows already retrieved for other issuers (814,874 records as of Oct 23, 2026, 8:59 PM ET) for the 12 issuers this person is listed on — nothing matched.

Public profiles and social

Websites and social links of the issuers Robert W. Croce is listed on: none on file. No website or social profile named in Earlens Corp's SEC filings (Form C, Reg A, Form ADV; checked Oct 24, 2026). Web search for this name: #76,438 of 374,652 in line (1,386 issuers searched so far). One-tap searches: Look further ↓

Look further

One-tap searches on sites we do not index ourselves, with the name pre-filled (Menlo Park, CA). Each opens in a new tab; what you find there is not verified by PartnerFacts.

Social and web

LinkedIn people search ↗Instagram ↗X (Twitter) ↗Facebook ↗YouTube ↗Google ↗Google Images ↗Google News ↗Meta Ad Library ↗

Courts

CourtListener / RECAP (federal) ↗PACER case locator (federal, login) ↗California — find the county court ↗Los Angeles Superior Court case search ↗Hillsborough County FL Clerk (HOVER) ↗Miami-Dade Clerk online case search ↗Maryland Judiciary case search ↗New Jersey state courts — find the court ↗

Securities regulators

SEC EDGAR full-text search ↗SEC action look-up ↗FINRA BrokerCheck ↗SEC IAPD adviser search ↗

Business registries

California Secretary of State business search ↗Florida Secretary of State business search ↗Maryland Secretary of State business search ↗New Jersey Secretary of State business search ↗OpenCorporates ↗

Change history

No corrections have been requested for this page.

Every fact links to its public-record source. Plain-English notes next to a fact are our reading of that fact, not a rating. Request a correction · Facts policy

Request a correction

Free. Logged with status: received → under review → fixed / confirmed with source.

Add a response

If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.

Monitor this person

Members get an email when Robert W. Croce appears on a new Form D, or when a court case or SEC action is matched to them. See plans →